RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies
NCT00529438
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
47
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Lymphoid Malignancies
Interventions
DRUG:
Bardoxolone methyl
Sponsor
Biogen